Resources from the same session
128MO - Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ advanced, unresectable or metastatic G/GEJ adenocarcinoma
Presenter: Sun Young Rha
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
129MO - Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2-positive (HER2+) advanced gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric06 (DG-06) final analysis
Presenter: Zhi Peng
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 128MO and 129MO
Presenter: Sylvie Lorenzen
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Slides
Webcast
130MO - EDGE-Gastric Arm A1: Phase II study of domvanalimab (D), zimberelimab (Z), and FOLFOX in first-line (1L) advanced gastroesophageal (GE) cancer
Presenter: Sun Young Rha
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
131MO - Tislelizumab (TIS) plus chemotherapy (Chemo) vs placebo (PBO) plus chemo as first-line (1L) treatment of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC): Patient reported outcomes (PRO) in the Asian subgroup of the RATIONALE-305 study
Presenter: Ken Kato
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Webcast
132MO - Anti-claudin18.2 (CLDN18.2) antibody-drug conjugate (ADC) IBI343 in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC): Updated results from a phase I study
Presenter: Jian Zhang
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
138MO - Baseline characteristics and molecular testing of patients with IDH1-mutated cholangiocarcinoma: Initial results from the phase IIIb ProvIDHe study
Presenter: Lorenza Rimassa
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 132MO and 138MO
Presenter: Angela Lamarca
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Webcast